Mabthera and platelet count decreased Patient Reports February 12, 2012

Mabthera Side Effects Report #5269429-6
Mabthera side effect was reported by a Physician from FRANCE on Mar 05, 2007. Male patient, 56 years of age, was diagnosed with rheumatoid arthritis

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, platelet count decreased, rheumatoid arthritis

. Mabthera dosage: unknown. During the same period patient was treated with CORTICOID, MOSCONTIN, AMLODIPINE BESYLATE, SECTRAL, COZAAR, VERCYTE, PLAVIX, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #6025586-5
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 17, 2008. Female patient was diagnosed with rheumatoid arthritis

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: platelet count decreased. Mabthera dosage: unknown. During the same period patient was treated with STEROIDS. Patient recovered.

Mabthera Side Effects Report #5941113-2
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Oct 20, 2008. Female patient, 52 years of age, was diagnosed with polyarthritis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: hepatic enzyme increased, platelet count decreased, sepsis

. Mabthera dosage: 1000 MG, UNK. During the same period patient was treated with MEXALEN, DIBONDRIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5965057-5
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Nov 11, 2008. Female patient, 52 years of age, was diagnosed with polyarthritis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: hepatic enzyme increased, platelet count decreased, sepsis

. Mabthera dosage: 1000 MG, UNK. During the same period patient was treated with MEXALEN, DIBONDRIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5595008-7
Mabthera side effect was reported by a Physician from JAPAN on Jan 09, 2008. Female patient, 76 years of age, weighting 97.66 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia

, septic shock, urinary tract infection

, white blood cell count decreased. Mabthera dosage: 530 MG, UNK. During the same period patient was treated with IFOSFAMIDE, CISPLATIN, ETOPOSIDE. Patient died on 04/28/2007.

Mabthera Side Effects Report #5632647-9
Mabthera side effect was reported by a Physician from JAPAN on Feb 12, 2008. Female patient, 76 years of age, weighting 97.66 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia

, septic shock, urinary tract infection

, white blood cell count decreased. Mabthera dosage: 530 MG, UNK. During the same period patient was treated with IFOSFAMIDE, CISPLATIN, ETOPOSIDE, MANNITOL. Patient died on 04/28/2007.

Mabthera Side Effects Report #4690705-X
Mabthera side effect was reported by a Physician from on May 31, 2005. Male patient, 76 years of age, weighting 139.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaphylactic reaction, auricular swelling, blood glucose increased, blood sodium decreased, blood urea increased, haematocrit decreased, infusion related reaction, platelet count decreased. Mabthera dosage: unknown. During the same period patient was treated with CICLOFOSFAMIDA, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, SALICYLIC ACID, ATENOLOL, FINASTERIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4819041-5
Mabthera side effect was reported by a Health Professional from POLAND on Oct 17, 2005. Male patient, 70 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood albumin increased, blood creatinine increased, haemoglobin decreased, ileus paralytic, large intestinal obstruction, platelet count decreased, pneumonia

, septic shock, white blood cell count decreased. Mabthera dosage: 700 MG, QD, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN PFS, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.

Mabthera Side Effects Report #4825018-6
Mabthera side effect was reported by a Health Professional from POLAND on Oct 27, 2005. Male patient, 70 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood albumin increased, blood creatinine increased, haemoglobin decreased, ileus paralytic, platelet count decreased, pneumonia

, septic shock. Mabthera dosage: 700 MG, QD, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN PFS, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.

Mabthera Side Effects Report #5028023-2
Mabthera side effect was reported by a Health Professional from SPAIN on Apr 07, 2006. Female patient, 68 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased. Mabthera dosage: 375 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADRIAMYCIN PFS, VINCRISTINE, PREDNISONE, NEORECORMON, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5091713-X
Mabthera side effect was reported by a Physician from SWEDEN on Aug 16, 2006. Female patient, 62 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased, pneumocystis jiroveci pneumonia, white blood cell count decreased. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4772999-5
Mabthera side effect was reported by a Consumer or non-health professional from JAPAN on Sept 06, 2005. Female patient, 58 years of age, weighting 121.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 386 MG, INTRAVENOUS. During the same period patient was treated with IBRITUMOMAB TIUXETAN, BLOPRESS, ADONA, YTTRIUM CHLORIDE HEXAHYDRATE, INDIUM TRICHLORIDE, MUCOSTA, HICEE, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4905311-9
Mabthera side effect was reported by a Consumer or non-health professional from JAPAN on Jan 23, 2006. Female patient, 58 years of age, weighting 121.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, haematocrit decreased, haemoglobin decreased, neutrophil count decreased, petechiae, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 386 MG, INTRAVENOUS. During the same period patient was treated with IBRITUMOMAB TIUXETAN, YTTRIUM CHLORIDE HEXAHYDRATE, INDIUM TRICHLORIDE, BLOPRESS, ADONA, MUCOSTA, HICEE, CIPROXIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4724089-5
Mabthera side effect was reported by a Health Professional from JAPAN on July 12, 2005. Female patient, 55 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: lymphocyte count decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 354 MG, INTRAVENOUS. During the same period patient was treated with ZEVALIN, TIMOLOL MALEATE, XALATAN, FLUMETHOLON, AMOBAN, CHLOR. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4890064-3
Mabthera side effect was reported by a Physician from JAPAN on Jan 06, 2006. Female patient, 55 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: lymphocyte count decreased, neutrophil count decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 354 MG, INTRAVENOUS. During the same period patient was treated with ZEVALIN, TIMOLOL MALEATE, XALATAN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4905350-8
Mabthera side effect was reported by a Consumer or non-health professional from JAPAN on Jan 24, 2006. Female patient, 55 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: neutrophil count decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 250 MG, INTRAVENOUS. During the same period patient was treated with YTTRIUM, INDIUM. Patient recovered.

Mabthera Side Effects Report #5228374-2
Mabthera side effect was reported by a Physician from CANADA on Jan 27, 2007. Female patient, 53 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplastic anaemia, hepatic cirrhosis, hepatic steatosis, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient recovered.

Mabthera Side Effects Report #5162050-X
Mabthera side effect was reported by a Physician from CANADA on Nov 10, 2006. Female patient, 53 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplastic anaemia, hepatic steatosis, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient recovered.

Mabthera Side Effects Report #4714682-8
Mabthera side effect was reported by a Physician from ARGENTINA on June 27, 2005. Male patient, 43 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: neutropenia, platelet count decreased, pleural effusion, respiratory distress. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient died on 08/14/2004.

Mabthera Side Effects Report #4891923-8
Mabthera side effect was reported by a Physician from GERMANY on Jan 09, 2006. Female patient, 40 years of age, weighting 119.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood cholesterol increased, bone marrow failure, candidiasis, cholelithiasis, leukopenia, lymphadenopathy, neutrophil percentage increased, platelet count decreased, pneumocystis jiroveci pneumonia. Mabthera dosage: 375 MG/KG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4564070-2
Mabthera side effect was reported by a Physician from on Jan 14, 2005. Female patient, 26 years of age, weighting 99.21 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, haematotoxicity, haemoglobin decreased, platelet count decreased, skin toxicity, white blood cell count decreased. Mabthera dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with METHOTREXATE, ETOPOSIDE, CYCLOPHOSPHAMIDE, ADRIABLASTINE, IFOSFAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5156804-3
Mabthera side effect was reported by a Physician from CANADA on Nov 01, 2006. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplastic anaemia, hepatic cirrhosis, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient recovered.

Mabthera Side Effects Report #4750039-1
Mabthera side effect was reported by a Physician from FRANCE on Aug 09, 2005. Male patient, 71 years of age, weighting 136.7 lb, was diagnosed with lymphoma

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 630 MG, QD, INTRAVENOUS. During the same period patient was treated with ONCOVIN, CYCLOPHOSPHAMIDE, CORTANCYL, ADRIABLASTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4754791-0
Mabthera side effect was reported by a Physician from FRANCE on Aug 16, 2005. Male patient, 71 years of age, weighting 136.7 lb, was diagnosed with lymphoma

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 630 MG, QD, INTRAVENOUS. During the same period patient was treated with ONCOVIN, CYCLOPHOSPHAMIDE, PREDNISONE, ADRIABLASTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5052940-0
Mabthera side effect was reported by a Health Professional from SPAIN on June 29, 2006. Female patient, 65 years of age, weighting 158.7 lb, was diagnosed with lymphoma

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased. Mabthera dosage: 375 MG/M2, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5281131-3
Mabthera side effect was reported by a Physician from CZECH REPUBLIC on Mar 12, 2007. Female patient, 60 years of age, was diagnosed with lymphoma

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: encephalopathy, haemoglobin decreased, neuropathy peripheral, neurotoxicity, platelet count decreased. Mabthera dosage: unknown. During the same period patient was treated with CISPLATIN, DEXAMETHASONE, CYTARABINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5150786-6
Mabthera side effect was reported by a Physician from FRANCE on Oct 26, 2006. Female patient, 68 years of age, weighting 125.7 lb, was diagnosed with leukaemia, anaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, phlebitis, platelet count decreased. Mabthera dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, DECTANCYL, ARANESP. Patient recovered.

Mabthera Side Effects Report #5754787-6
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 19, 2008. Female patient, weighting 70.55 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Mabthera. After drug was administered, patient experienced the following side effects: platelet count decreased. Mabthera dosage: 431 MG, Q2W. Patient recovered.

Mabthera Side Effects Report #4644290-9
Mabthera side effect was reported by a Physician from on Apr 13, 2005. Male patient, 79 years of age, weighting 152.1 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, blood lactate dehydrogenase increased, c-reactive protein increased, haemoglobin decreased, platelet count decreased, pneumonia

, respiratory failure, septic shock, ventricular fibrillation. Mabthera dosage: 375 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, DISALUNIL, BISOPROLOL, TAMSULOSIN, ATORVASTATIN. Patient was hospitalized. Patient died.

Mabthera Side Effects Report #5281330-0
Mabthera side effect was reported by a Physician from SWITZERLAND on Mar 14, 2007. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematotoxicity, haemoglobin decreased, multi-organ failure, platelet count decreased, septic shock, white blood cell count decreased. Mabthera dosage: 700 MG. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient died on 09/01/2005.

Mabthera Side Effects Report #4649841-6
Mabthera side effect was reported by a Physician from on Apr 18, 2005. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, febrile neutropenia, haemoglobin decreased, humerus fracture, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CISPLATIN, CYTARABINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4556897-8
Mabthera side effect was reported by a Physician from on Jan 06, 2005. Female patient, 61 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acidosis, anaemia, bacterial sepsis, disease progression, disseminated intravascular coagulation, laboratory test abnormal, neutropenia, platelet count decreased, tachypnoea. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CISPLATIN, CYTOSINE ARABINOSIDE, DEXAMETHASONE. Patient was hospitalized. Patient died on 12/25/2004.

Mabthera Side Effects Report #4568352-X
Mabthera side effect was reported by a Physician from on Jan 18, 2005. Female patient, 53 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: asthenia, dehydration, febrile neutropenia, haemoglobin decreased, nausea

, platelet count decreased, renal impairment, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5806646-8
Mabthera side effect was reported by a Health Professional from UNITED STATES on July 01, 2008. Female patient, weighting 110.2 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased, renal haemorrhage. Mabthera dosage: 375 MG/M2, Q2W. During the same period patient was treated with ENZASTAURIN, GEMCITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4669465-4
Mabthera side effect was reported by a Physician from on May 06, 2005. Female patient, 79 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenia, platelet count decreased, urinary tract infection

, white blood cell count decreased. Mabthera dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, PHENERGAN, PREDNISONE. Patient recovered.

Mabthera Side Effects Report #5085972-7
Mabthera side effect was reported by a Physician from BELGIUM on Aug 09, 2006. Female patient, 74 years of age, weighting 123.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, febrile neutropenia, haemolytic anaemia, histiocytosis haematophagic, platelet count decreased. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, ALLOPURINOL, ARANESP. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4791813-5
Mabthera side effect was reported by a Physician from BELGIUM on Sept 22, 2005. Female patient, 74 years of age, weighting 123.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood urea increased, febrile neutropenia, haemolytic anaemia, histiocytosis haematophagic, platelet count decreased. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, ALLOPURINOL, ARANESP. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5015849-4
Mabthera side effect was reported by a Physician from BELGIUM on May 20, 2006. Female patient, 74 years of age, weighting 123.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood urea increased, febrile neutropenia, haemolytic anaemia, histiocytosis haematophagic, platelet count decreased, white blood cell count decreased. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ALLPURINOL, ARANESP, FLUDARABINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4745704-6
Mabthera side effect was reported by a Health Professional from GERMANY on Aug 01, 2005. Male patient, 64 years of age, weighting 159.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: atelectasis, febrile neutropenia, haemoglobin decreased, platelet count decreased, pleural effusion, pleural fibrosis, red blood cell count decreased, sepsis

. Mabthera dosage: 713 MG INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, BACTRIM, ACYCLOVIR, BLOOD PRODUCTS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4682002-3
Mabthera side effect was reported by a Physician from on May 20, 2005. Male patient, 63 years of age, weighting 213.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, neutropenia, platelet count decreased. Mabthera dosage: 840 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, BACTRIM DS. Patient recovered.

Mabthera Side Effects Report #4696099-8
Mabthera side effect was reported by a Physician from on June 03, 2005. Male patient, 63 years of age, weighting 213.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, neutropenia, platelet count decreased. Mabthera dosage: 840 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, BACTRIM DS. Patient recovered.

Mabthera Side Effects Report #5047231-8
Mabthera side effect was reported by a Health Professional from AUSTRALIA on June 16, 2006. Male patient, 62 years of age, weighting 125.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, fluid intake reduced, haematocrit decreased, haemoglobin decreased, jc virus infection, platelet count decreased, white blood cell count decreased. Mabthera dosage: 785 MG, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, BACTRIM, VALTREX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5055325-6
Mabthera side effect was reported by a Health Professional from AUSTRALIA on June 30, 2006. Male patient, 62 years of age, weighting 125.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, fluid intake reduced, haematocrit decreased, haemoglobin decreased, jc virus infection, platelet count decreased, virus urine test positive, white blood cell count decreased. Mabthera dosage: 785 MG, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, BACTRIM, VALTREX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5085560-2
Mabthera side effect was reported by a Health Professional from AUSTRALIA on June 30, 2006. Male patient, 62 years of age, weighting 125.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, fluid intake reduced, haematocrit decreased, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 785 MG, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, BACTRIM, VALTREX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4821956-9
Mabthera side effect was reported by a Health Professional from GERMANY on Oct 25, 2005. Male patient, 58 years of age, weighting 238.1 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, bone marrow failure, bone marrow toxicity, gamma-glutamyltransferase increased, hyperhidrosis, leukopenia, platelet count decreased, splenomegaly. Mabthera dosage: 500 MG,. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, COTRIMTE, FUROSEMIDE, ESIDRIX. Patient recovered.

Mabthera Side Effects Report #4883255-9
Mabthera side effect was reported by a Physician from AUSTRALIA on Jan 04, 2006. Male patient, 40 years of age, weighting 169.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: ear pain, haemoglobin decreased, infection

, laboratory test abnormal, neutropenia, platelet count decreased, rash

, red blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, CHLARAXTYNE, DIFLUCAN, VALACYCLOVIR, MAXOLON, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4918169-9
Mabthera side effect was reported by a Physician from AUSTRALIA on Feb 02, 2006. Male patient, 40 years of age, weighting 169.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: ear pain, haemoglobin decreased, infection

, neutropenia, platelet count decreased, red blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, DIFLUCAN, VALACYCLOVIR, MAXOLON, ALLOPURINOL, TRIMETHOPRIM. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4661256-3
Mabthera side effect was reported by a Physician from on Apr 27, 2005. Male patient was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, colitis, haematocrit decreased, leukopenia, neutropenia, platelet count decreased. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4757121-3
Mabthera side effect was reported by a Physician from GERMANY on Aug 18, 2005. Male patient, weighting 238.1 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bone marrow depression, leukopenia, platelet count decreased, viral infection

. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, COTRIMTE. Patient recovered.

Mabthera Side Effects Report #4816221-X
Mabthera side effect was reported by a Physician from NEW ZEALAND on Oct 19, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4816222-1
Mabthera side effect was reported by a Physician from NEW ZEALAND on Oct 19, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: complications of bone marrow transplant, febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 700 MG. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5104254-8
Mabthera side effect was reported by a Physician from THAILAND on Sept 01, 2006. Male patient, 49 years of age, weighting 111.1 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, blood glucose decreased, blood pressure decreased, platelet count decreased, pneumonia

, sepsis

. Mabthera dosage: 585 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISOLONE, FE FUMARATE, VIT B, VITAMIN B, CYANOCOBALAMIN. Patient died on 08/07/2006.

Mabthera Side Effects Report #4897058-2
Mabthera side effect was reported by a Consumer or non-health professional from POLAND on Jan 17, 2006. Female patient, 80 years of age, weighting 143.3 lb, was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, condition aggravated, platelet count decreased, pneumonia

, shock, white blood cell count decreased. Mabthera dosage: 600 MG, QD, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Mabthera and platelet count decreased

SideEffects101.com

Mabthera and platelet count decreased Patient Reports February 12, 2012

side effects of Mabthera